Literature DB >> 19843739

Hepatic iron deposition in patients with liver disease: preliminary experience with breath-hold multiecho T2*-weighted sequence.

Hersh Chandarana1, Ruth P Lim, Jens H Jensen, Cristina H Hajdu, Mariela Losada, James S Babb, Steve Huffman, Bachir Taouli.   

Abstract

OBJECTIVE: The purpose of this study was to conduct, using histopathologic examination as the reference standard, a preliminary evaluation of the use of a breath-hold multiecho T2(*)-weighted MRI sequence in the detection and quantification of hepatic iron deposition in patients with liver disease.
MATERIALS AND METHODS: The images of 43 patients with liver disease who underwent 1.5-T MRI of the liver that included a multiecho T2(*)-weighted sequence who also underwent concomitant liver biopsy or liver transplantation were assessed. Two independent observers measured hepatic T2(*) by placing regions of interest in the hepatic parenchyma. Hepatic T2(*) values were compared between patients stratified by hepatic iron grade and were correlated with histopathologic iron grade. Receiver operating characteristics analysis was performed to assess the accuracy of images obtained with the hepatic T2(*)-weighted sequence in the diagnosis of iron deposition.
RESULTS: Patients with iron deposition had shorter hepatic T2(*) values than did patients without iron deposition (mean T2(*), 17.7 vs 32.3 milliseconds with pooled data from both observers; p < 0.0001). Patients with iron grade 3 or greater had shorter T2(*) values than those with iron grade 2 or less (10.1 vs 20.8 milliseconds; p < 0.0001). There was a strong negative correlation between hepatic T2(*) and histopathologic iron grade (r = -0.849; p < 0.0001). For the prediction of iron grades 1 or greater and 3 or greater, area under the curve, sensitivity, and specificity were 0.968-0.982, 90.5-100%, and 100-97.3% at T2(*) cutoffs of less than 24 and less than 14 milliseconds, respectively.
CONCLUSION: Hepatic iron overload in patients with liver disease can be assessed rapidly and accurately with MRI performed with a breath-hold T2(*)-weighted sequence.

Entities:  

Mesh:

Year:  2009        PMID: 19843739     DOI: 10.2214/AJR.08.1996

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  18 in total

Review 1.  Magnetic resonance imaging quantification of liver iron.

Authors:  Claude B Sirlin; Scott B Reeder
Journal:  Magn Reson Imaging Clin N Am       Date:  2010-08       Impact factor: 2.266

2.  Evaluation of MR imaging with T1 and T2* mapping for the determination of hepatic iron overload.

Authors:  B Henninger; C Kremser; S Rauch; R Eder; H Zoller; A Finkenstedt; H J Michaely; M Schocke
Journal:  Eur Radiol       Date:  2012-05-30       Impact factor: 5.315

Review 3.  CCSVI and MS: no meaning, no fact.

Authors:  Claudio Baracchini; Matteo Atzori; Paolo Gallo
Journal:  Neurol Sci       Date:  2012-05-09       Impact factor: 3.307

4.  Bone marrow uptake of ferumoxytol: a preliminary study in healthy human subjects.

Authors:  Pippa Storey; Arnaldo A Arbini
Journal:  J Magn Reson Imaging       Date:  2013-10-10       Impact factor: 4.813

5.  Pretreatment assessment of hepatocellular carcinoma: expert consensus statement.

Authors:  Jean-Nicolas Vauthey; Elijah Dixon; Eddie K Abdalla; W Scott Helton; Timothy M Pawlik; Bachir Taouli; Antoine Brouquet; Reid B Adams
Journal:  HPB (Oxford)       Date:  2010-06       Impact factor: 3.647

Review 6.  Clinical utility of quantitative imaging.

Authors:  Andrew B Rosenkrantz; Mishal Mendiratta-Lala; Brian J Bartholmai; Dhakshinamoorthy Ganeshan; Richard G Abramson; Kirsteen R Burton; John-Paul J Yu; Ernest M Scalzetti; Thomas E Yankeelov; Rathan M Subramaniam; Leon Lenchik
Journal:  Acad Radiol       Date:  2014-10-22       Impact factor: 3.173

7.  Assessment of liver iron overload by 3 T MRI.

Authors:  A Paisant; A Boulic; E Bardou-Jacquet; E Bannier; G d'Assignies; F Lainé; B Turlin; Y Gandon
Journal:  Abdom Radiol (NY)       Date:  2017-06

8.  Does fat suppression via chemically selective saturation affect R2*-MRI for transfusional iron overload assessment? A clinical evaluation at 1.5T and 3T.

Authors:  Axel J Krafft; Ralf B Loeffler; Ruitian Song; Xiao Bian; M Beth McCarville; Jane S Hankins; Claudia M Hillenbrand
Journal:  Magn Reson Med       Date:  2015-08-26       Impact factor: 4.668

9.  3D Multi-Echo Dixon technique for simultaneous assessment of liver steatosis and iron overload in patients with chronic liver diseases: a feasibility study.

Authors:  Fubi Hu; Ru Yang; Zixing Huang; Min Wang; Fang Yuan; Chunchao Xia; Yi Wei; Bin Song
Journal:  Quant Imaging Med Surg       Date:  2019-06

10.  An in vitro and in vivo analysis of the correlation between susceptibility-weighted imaging phase values and R2* in cirrhotic livers.

Authors:  Ran Tao; Jiuquan Zhang; Yongming Dai; Zhonglan You; Yi Fan; Jinguo Cui; Jian Wang
Journal:  PLoS One       Date:  2012-09-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.